Depomed Company Profile (NASDAQ:DEPO)

About Depomed

Depomed logoDepomed, Inc. is a specialty pharmaceutical company focused on pain and other central nervous system (CNS) conditions. The Company's products include NUCYNTA ER (tapentadol extended release tablets), which is a product for the management of pain severe enough to require daily, around-the-clock, long term opioid treatment, including neuropathic pain associated with diabetic peripheral neuropathy in adults, and for which alternate treatment options are inadequate; NUCYNTA (tapentadol), which is an immediate release version of tapentadol for the management of moderate to severe acute pain in adults; Gralise, which is a once-daily product for the management of postherpetic neuralgia; CAMBIA, which is a non-steroidal anti-inflammatory drug (NSAID) for the acute treatment of migraine attacks; Zipsor, which is a NSAID for the treatment of mild to moderate acute pain, and Lazanda nasal spray, which is used for the management of break through pain in cancer patients.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Other
  • Sub-Industry: Pharmaceuticals
  • Exchange: NASDAQ
  • Symbol: DEPO
  • CUSIP: 24990810
Key Metrics:
  • Previous Close: $24.53
  • 50 Day Moving Average: $21.78
  • 200 Day Moving Average: $18.92
  • 52-Week Range: $12.25 - $25.50
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 16.57
  • P/E Growth: 1.05
  • Market Cap: $1.51B
  • Outstanding Shares: 61,366,000
  • Beta: 1.03
Profitability:
  • Net Margins: -16.89%
  • Return on Equity: 3.71%
  • Return on Assets: 0.88%
Debt:
  • Debt-to-Equity Ratio: 2.39%
  • Current Ratio: 1.06%
  • Quick Ratio: 1.01%
Additional Links:
Companies Related to Depomed:

Analyst Ratings

Consensus Ratings for Depomed (NASDAQ:DEPO) (?)
Ratings Breakdown: 4 Hold Ratings, 8 Buy Ratings
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $23.42 (4.54% downside)

Analysts' Ratings History for Depomed (NASDAQ:DEPO)
Show:
DateFirmActionRatingPrice TargetDetails
9/28/2016Janney Montgomery ScottReiterated RatingBuy$28.00View Rating Details
9/23/2016RBC Capital MarketsReiterated RatingSector Perform$22.00View Rating Details
9/16/2016MizuhoBoost Price TargetBuy$23.00 -> $27.00View Rating Details
8/11/2016Cantor FitzgeraldReiterated RatingBuyView Rating Details
8/4/2016Piper Jaffray Cos.Reiterated RatingNeutral$18.00 -> $19.00View Rating Details
8/4/2016JMP SecuritiesLower Price TargetMarket Outperform$28.00 -> $22.00View Rating Details
7/18/2016Leerink SwannReiterated RatingPositiveView Rating Details
7/11/2016Royal Bank Of CanadaReiterated RatingHoldView Rating Details
3/28/2016Roth CapitalReiterated RatingBuyView Rating Details
3/24/2016Northland SecuritiesInitiated CoverageOutperform$22.00View Rating Details
2/24/2016WallachBeth CapitalLower Price TargetBuy$33.00 -> $27.00View Rating Details
12/3/2015Morgan StanleyInitiated CoverageEqual -> Equal Weight$21.00View Rating Details
(Data available from 9/28/2014 forward)

Earnings

Earnings History for Depomed (NASDAQ:DEPO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/7/2016        
8/3/2016Q2$0.26$0.27$118.20 million$116.70 millionViewListenView Earnings Details
5/5/2016Q1$0.17$0.12$106.88 million$104.60 millionViewListenView Earnings Details
2/22/2016Q415$0.29$0.16$110.19 million$111.20 millionViewListenView Earnings Details
11/9/2015Q3$0.19$0.33$101.64 million$105.00 millionViewListenView Earnings Details
7/29/2015Q215($0.45)$0.27$88.33 million$94.30 millionViewListenView Earnings Details
5/11/2015Q115$0.07($0.13)$33.80 million$31.70 millionViewListenView Earnings Details
2/23/2015Q414$0.07$0.21$44.66 million$33.90 millionViewListenView Earnings Details
11/5/2014Q314($0.04)$0.03$41.50 million$51.49 millionViewListenView Earnings Details
8/6/2014Q214($0.08)($0.01)$38.03 million$67.70 millionViewListenView Earnings Details
5/8/2014Q114$0.10($0.01)$53.57 million$76.50 millionViewListenView Earnings Details
3/12/2014Q413($0.21)$0.72$19.06 million$40.60 millionViewListenView Earnings Details
11/5/2013Q313$0.07$0.11$35.55 million$37.50 millionViewListenView Earnings Details
8/7/2013Q2 2013($0.05)$0.01$29.87 million$30.00 millionViewListenView Earnings Details
5/8/2013Q1 2013($0.06)($0.10)$28.93 million$26.20 millionViewListenView Earnings Details
2/20/2013Q4 2012($0.11)($0.07)$26.48 million$26.60 millionViewListenView Earnings Details
11/5/2012Q312($0.11)($0.03)$28.06 million$33.30 millionViewN/AView Earnings Details
8/2/2012($0.22)($0.28)ViewN/AView Earnings Details
5/8/2012($0.24)($0.16)ViewN/AView Earnings Details
3/8/2012($0.31)($0.25)ViewN/AView Earnings Details
11/1/2011($0.23)($0.15)ViewN/AView Earnings Details
8/1/2011($0.05)($0.11)ViewN/AView Earnings Details
5/5/2011$1.05$1.77ViewN/AView Earnings Details
3/3/2011$0.06$0.03ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Depomed (NASDAQ:DEPO)
Current Year EPS Consensus Estimate: $1.21 EPS
Next Year EPS Consensus Estimate: $1.48 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.22)($0.22)($0.22)
Q2 20161($0.14)($0.14)($0.14)
Q3 20161$0.04$0.04$0.04
Q4 20161$0.09$0.09$0.09
Q1 20171$0.04$0.04$0.04
Q2 20171$0.07$0.07$0.07
Q3 20171$0.11$0.11$0.11
Q4 20171$0.22$0.22$0.22
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Depomed (NASDAQ:DEPO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Depomed (NASDAQ:DEPO)
Insider Ownership Percentage: 5.12%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/21/2016Thadd M VargasVPSell11,250$25.00$281,250.00View SEC Filing  
8/10/2016August J. MorettiCFOSell5,000$21.40$107,000.00View SEC Filing  
8/10/2016Thadd M VargasVPSell26,290$20.92$549,986.80View SEC Filing  
5/23/2016Thadd M VargasVPSell15,000$20.00$300,000.00View SEC Filing  
5/10/2016Thadd M VargasVPSell15,000$17.64$264,600.00View SEC Filing  
5/9/2016August J MorettiCFOSell5,000$18.00$90,000.00View SEC Filing  
3/11/2016Thadd M VargasVPSell23,000$16.00$368,000.00View SEC Filing  
12/3/2015August J. MorettiCFOSell15,000$18.11$271,650.00View SEC Filing  
6/12/2015Thadd M VargasVPSell5,000$20.70$103,500.00View SEC Filing  
12/2/2014August J MorettiCFOSell5,339$15.85$84,623.15View SEC Filing  
12/2/2014James A SchoeneckCEOSell36,727$15.85$582,122.95View SEC Filing  
12/2/2014Thadd M VargasVPSell8,247$15.85$130,714.95View SEC Filing  
11/19/2014Matthew M GoslingVPSell71,000$15.36$1,090,560.00View SEC Filing  
3/14/2014James SchoeneckCEOSell17,000$14.54$247,180.00View SEC Filing  
3/14/2014Matthew GoslingVPSell21,875$14.74$322,437.50View SEC Filing  
12/2/2013Michael Md SweeneyCMOSell4,270$8.40$35,868.00View SEC Filing  
12/2/2013Thadd VargasVPSell5,296$8.40$44,486.40View SEC Filing  
5/10/2013James A SchoeneckCEOBuy25,000$5.11$127,750.00View SEC Filing  
3/6/2013Karen A DawesDirectorBuy2,000$5.96$11,920.00View SEC Filing  
8/14/2012Peter D StapleDirectorBuy5,000$5.01$25,050.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Depomed (NASDAQ:DEPO)
DateHeadline
News IconDepomed, Inc. (NASDAQ:DEPO) Latest Broker Views - NewsDen (NASDAQ:DEPO)
newsden.net - September 28 at 4:28 PM
streetinsider.com logoJanney Sees Potential DepoMed (DEPO) Court Decision Delay (NASDAQ:DEPO)
www.streetinsider.com - September 28 at 9:30 AM
News IconSell-side is Weighing in on Depomed, Inc. (NASDAQ:DEPO) Earnings & Targets - Frisco Fastball (NASDAQ:DEPO)
friscofastball.com - September 26 at 4:47 PM
News IconSell-side is Weighing in on Depomed, Inc. (NASDAQ:DEPO) Earnings & Targets - Frisco Fastball (NASDAQ:DEPO)
friscofastball.com - September 26 at 4:47 PM
mysmartrend.com logoDepomed Has Returned 21.1% Since SmarTrend Recommendation (DEPO) (NASDAQ:DEPO)
www.mysmartrend.com - September 23 at 4:23 PM
insidermonkey.com logoDepomed Inc (DEPO): Starboard Value LP Schedules Special Meeting of Shareholders - Insider Monkey (blog) (NASDAQ:DEPO)
www.insidermonkey.com - September 23 at 9:39 AM
News IconDepomed Inc (DEPO): Starboard Value LP Schedules Special Meeting of Shareholders (NASDAQ:DEPO)
feedproxy.google.com - September 22 at 11:40 AM
prnewswire.com logoDepomed Supports the American Chronic Pain Association's Toolkit for Primary Care Providers (NASDAQ:DEPO)
www.prnewswire.com - September 22 at 10:10 AM
seekingalpha.com logoHow Much Is Depomed Worth As A Buyout Target? - Seeking Alpha (NASDAQ:DEPO)
seekingalpha.com - September 21 at 5:07 PM
investopedia.com logoReport: Depomed Is Attempting to Sell Itself (NASDAQ:DEPO)
www.investopedia.com - September 21 at 8:53 AM
News IconVolatile Measures on Top- Isle of Capri Casinos (NASDAQ:ISLE), Depomed, Inc. (NASDAQ:DEPO), Alere (NYSE:ALR) - Seneca Globe (NASDAQ:DEPO)
www.senecaglobe.com - September 20 at 8:17 AM
seekingalpha.com logoDepomed: Acquisition Target? - Seeking Alpha (NASDAQ:DEPO)
seekingalpha.com - September 20 at 8:17 AM
marketwatch.com logoStarboard delivers special shareholder meeting request to Depomed - MarketWatch (NASDAQ:DEPO)
www.marketwatch.com - September 19 at 3:28 PM
News IconTraders Watch list: Depomed Inc (NASDAQ:DEPO), Valeant Pharmaceuticals Intl Inc (NYSE:VRX), Fifth Third Bancorp ... - NYSE Journal (press release) (NASDAQ:DEPO)
stockznews.com - September 19 at 3:28 PM
News IconHC Stocks in Hub! Immune Pharmaceuticals Inc (IMNP), Depomed Inc (NASDAQ:DEPO) - share market updates (press release) (NASDAQ:DEPO)
sharemarketupdates.com - September 19 at 3:28 PM
prnewswire.com logoStarboard Delivers Special Meeting Request to Depomed and Issues Letter to Depomed Shareholders - PR Newswire (press release) (NASDAQ:DEPO)
www.prnewswire.com - September 19 at 3:28 PM
reuters.com logoAustralian port sold for $7.3 billion to group including Chinese fund (NASDAQ:DEPO)
uk.reuters.com - September 19 at 9:16 AM
finance.yahoo.com logoStarboard Delivers Special Meeting Request to Depomed and Issues Letter to Depomed Shareholders (NASDAQ:DEPO)
finance.yahoo.com - September 19 at 9:16 AM
marketwatch.com logoStarboard delivers special shareholder meeting request to Depomed (NASDAQ:DEPO)
www.marketwatch.com - September 19 at 9:16 AM
finance.yahoo.com logoStarboard sets date for special meeting of Depomed shareholders (NASDAQ:DEPO)
finance.yahoo.com - September 19 at 9:16 AM
investorplace.com logoDepomed Inc (DEPO) Stock Soars on Sale Buzz - Investorplace.com (NASDAQ:DEPO)
investorplace.com - September 18 at 4:28 PM
finance.yahoo.com logo5:22 pm DepoMed confirms it received request to call special meeting of shareholders (NASDAQ:DEPO)
finance.yahoo.com - September 18 at 9:15 AM
nasdaq.com logoMid-Day Market Update: Novavax Tumbles Following Failed Trial; Depomed Shares Surge - Nasdaq (NASDAQ:DEPO)
www.nasdaq.com - September 17 at 4:29 PM
benzinga.com logoDepomed, Inc. (NASDAQ:DEPO), GenMark Diagnostics, Inc ... - Benzinga (NASDAQ:DEPO)
www.benzinga.com - September 17 at 4:29 PM
nasdaq.com logoDepomed Receives Request to Call Special Meeting of Shareholders (NASDAQ:DEPO)
www.nasdaq.com - September 17 at 9:21 AM
wsj.com logoDepomed Sets Nov. 15 Meeting After Starboard Request (NASDAQ:DEPO)
www.wsj.com - September 17 at 9:21 AM
wsj.com logo[$$] Depomed Sets Nov. 15 Meeting After Starboard Request (NASDAQ:DEPO)
www.wsj.com - September 17 at 9:21 AM
bizjournals.com logoWhy this East Bay drug company may be attractive to a buyer (NASDAQ:DEPO)
feeds.bizjournals.com - September 16 at 7:12 PM
fool.com logoWhy Avis Budget Group, Depomed, and Community Health Systems Jumped Today (NASDAQ:DEPO)
www.fool.com - September 16 at 7:12 PM
streetinsider.com logoDepomed (DEPO) Back in Play Amid Recent Chatter; Valuation Remains Below Horizon Offer - Mizuho (NASDAQ:DEPO)
www.streetinsider.com - September 16 at 4:30 PM
schaeffersresearch.com logoBuzz Stocks: Deutsche Bank AG (USA), Twitter Inc, and Depomed Inc (NASDAQ:DEPO)
www.schaeffersresearch.com - September 16 at 4:30 PM
News IconDepoMed shares up; drugmaker reportedly preparing sale (NASDAQ:DEPO)
larampadinapoli.com - September 16 at 4:30 PM
fool.com logoWhy DepoMed's Shares Are Jumping 12% Today (NASDAQ:DEPO)
www.fool.com - September 16 at 4:30 PM
uk.finance.yahoo.com logoUS STOCKS-Futures drop with oil prices (NASDAQ:DEPO)
uk.finance.yahoo.com - September 16 at 4:30 PM
thestreet.com logoStocks End Volatile Week With Fed Meeting in Focus (NASDAQ:DEPO)
www.thestreet.com - September 16 at 4:30 PM
investorplace.com logoDepomed Inc (DEPO) Stock Soars on Sale Buzz (NASDAQ:DEPO)
investorplace.com - September 16 at 12:27 PM
seekingalpha.com logoDepomed puts itself on the block; shares up 14% premarket (NASDAQ:DEPO)
seekingalpha.com - September 16 at 9:28 AM
News IconWhat are Research Firms Saying About Depomed, Inc. (NASDAQ:DEPO)? - Frisco Fastball (NASDAQ:DEPO)
friscofastball.com - September 16 at 8:17 AM
marketwatch.com logoDepoMed shares jump on report drugmaker preparing sale - MarketWatch (NASDAQ:DEPO)
www.marketwatch.com - September 16 at 8:17 AM
News IconDepomed, Inc.'s (DEPO): Traders Limelight - Hot Stocks Point (NASDAQ:DEPO)
www.hotstockspoint.com - September 16 at 8:17 AM
reuters.com logoExclusive: Drugmaker Depomed prepares to explore a sale - sources - Reuters (NASDAQ:DEPO)
www.reuters.com - September 16 at 8:17 AM
sg.finance.yahoo.com logoExclusive: Drugmaker Depomed prepares to explore a sale - sources (NASDAQ:DEPO)
sg.finance.yahoo.com - September 16 at 8:17 AM
marketwatch.com logoDepoMed shares jump on report drugmaker preparing sale (NASDAQ:DEPO)
www.marketwatch.com - September 16 at 8:17 AM
News IconStock Perspective: Depomed, Inc. (NASDAQ:DEPO) Company Earnings Watch - Frisco Fastball (NASDAQ:DEPO)
friscofastball.com - September 15 at 8:24 AM
News IconAnalysts Valuations For Two Stocks: Sangamo Biosciences, Inc. (NASDAQ:SGMO), Depomed Inc (NASDAQ:DEPO) - The Voice Registrar (NASDAQ:DEPO)
voiceregistrar.com - September 15 at 8:24 AM
News IconDepomed Inc. (NASDAQ: DEPO) Buy Rating Reiterated at Janney Montgomery Scott - BNB Daily (blog) (NASDAQ:DEPO)
www.baseball-news-blog.com - September 15 at 8:24 AM
marketnewsvideo.com logoShort Interest Jumps 13.6% For DEPO (NASDAQ:DEPO)
www.marketnewsvideo.com - September 14 at 8:46 AM
streetinsider.com logoDepomed (DEPO): August Prescription Data Tracking At High End Of Estimates - Janney (NASDAQ:DEPO)
www.streetinsider.com - September 14 at 8:46 AM
finance.yahoo.com logoActivist Starboard demands rapid changes at Perrigo (NASDAQ:DEPO)
finance.yahoo.com - September 12 at 4:24 PM
investornewswire.com logoDepomed, Inc. (NASDAQ:DEPO) Expects Sales Of $916 - Investor Newswire (NASDAQ:DEPO)
www.investornewswire.com - September 10 at 9:12 AM

Social

Depomed (NASDAQ:DEPO) Chart for Wednesday, September, 28, 2016


Last Updated on 9/28/2016 by MarketBeat.com Staff